Toralf Roch

9PUBLICATIONS
31CO-AUTHORS
Haematological tumoursPeripheral nervous systemApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Humoural immunology and immunochemistryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 19, 2026
Acute COVID-19 is associated with altered CD8 T-cells indicative of impaired ability to control Epstein-Barr virus reactivation.

|Mar 29, 2023
Differential Expression of microRNAs in Serum of Patients with Chronic Painful Polyneuropathy and Healthy Age-Matched Controls.

Antonio Pellegrino, Sophie-Charlotte Fabig, Dilara Kersebaum

|Dec 02, 2022
Toll-like receptors control the accumulation of neutrophils in lymph nodes that expand CD4+ T cells during experimental autoimmune encephalomyelitis.

Ping Shen, Madlen Rother, Ulrik Stervbo

|Jan 18, 2021
Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatment.

Toralf Roch, Claudia Giesecke-Thiel, Arturo Blazquez-Navarro

|Jan 14, 2021
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer.

Tino Vollmer, Stephan Schlickeiser, Leila Amini

|Nov 05, 2020
Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins.

Ulrik Stervbo, Sven Rahmann, Toralf Roch

Pageof 2

Frequent Collaborators

7 joint publications

Ulrik Stervbo

4 joint publications

Constantin J Thieme

3 joint publications

Nina Babel

3 joint publications

Timm H Westhoff